99 Caspofungin vs. caspofungin combined with liposomal amphotericin B for the treatment of cerebral aspergillosis in a nursing rat model  by Strahm, R. et al.
S56 International Journal o[ In[ectious Diseases (2006) 10(S1 ) Abstracts 
99 
Caspofungin vs. Caspofungin Combined with 
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Cerebral Aspergillosis in a Nursing Rat Model 
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A Negative Procalcitonin (PCT) Test as an 
Indicator of Fever of Non-Bacterial Etiology in 
Neutropenic Cancer Patients with FUO 
R. Strahm, S.L. Leib, J. Kummer, S. Zimmer[i*. 
Institute [or Infectious Diseases University of 
Bern, Switzerland 
Background: Cerebral aspergi[[osis is associated 
with an unacceptably high mortality despite anti- 
funga[ treatment. 
Objectives: To compare the efficacy of caspofun- 
gin combined with [iposoma[ amphotericin B vs. 
caspofungin alone for the treatment of cerebral 
aspergi[[osis in immunocompetent nursing rats. 
Methods: ELeven-day-oLd non-immunosuppressed 
Wistar Wl rats were infected by intracisterna[ in- 
jection of 10pL of a conidia[ suspension of As- 
pergi[[us fumigatus. Treatment started 18h after 
infection and was given for 10 days. Regimens 
were caspofungin 1 mg/kg/d i.p. (n=20) and [i- 
posoma[ amphotericin B 5 mg/kg/d + caspofungin 
lmg/kg/d i.p. (n= 21).lnfected controls (n=14) 
were given NaC[ 0.9% or glucose 5% i.p. 
Results: ControLs consistently showed symptoms 
of cerebra[ AsperBillus infection. Their mean sur- 
vival time was 4.4 days. Treatment significantly 
increased survival time to 10.5 and 9.3 days for 
caspofungin alone and caspofungin combined with 
amphotericin B, respectively. The difference be- 
tween treatment regimens was not significant. CNS 
fungus burden determined by culture of corti- 
cal homogenates declined over time; interestingLy, 
there was no significant difference between con- 
trots and treated animals. Two animals in each 
treatment group had sterile brain cultures. Fun- 
ga[ dissemination determined by culture of kidney 
homogenates was found in 7/14 controls, 0/20 an- 
imals treated with caspofungin, and 1/21 animals 
of the combination group. 
Conclusion: Caspofungin atone and in combina- 
tion with [iposoma[ amphotericin B significantly 
increases survival time in a Lethal mode[ of cerebra[ 
aspergi[[osis. RemarkabLy, CNS fungus burden did 
not differ between controls and treated animals. 
The hypothesis that antifunga[ treatment may re- 
sult in a decreased inflammatory reaction is being 
further investigated. 
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Objectives: FUO accounts for 25-50% of at( febrile 
episodes (FE) in neutropenic cancer patients and 
may reflect the presence either of a non-infectious 
fever or of an occult infection. Given that infec- 
tion cannot be ruled out, most patients with fever 
of unknown origin (FUO) are treated with broad- 
spectrum antibiotics for extended periods of time 
(IDSA, CID, 2002). Identification of patients with 
fever of non-bacteria( etiology, in whom antibi- 
otics could be stopped rapidly (i.e. within 48-72 h 
of fever onset), would help to reduce treatment 
costs, adverse events and minimize the risk of 
development of resistance. In children with menin- 
gitis and in criticaLLy it( patients, PCT has been 
shown to distinguish bacteria[ from viral infections 
or from inflammatory diseases. The aim of the 
present study was to evaluate the utility of PCT 
for the management of neutropenic FUO. 
Methods: 171 FE in 125 consecutive neutropenic 
patients undergoing intensive chemotherapy for 
hematoLogicaL malignancies were studied prospec- 
tively over 18 months. FE were classified as micro- 
bioLogicaLLy (MDI) or cLinicaLLy (CDI) documented in- 
fections and FUO according to standard definitions 
(ICHS, JID, 1990). PLasma concentrations of PCT 
(KRYPTOR-PCT, BRAHMS, Germany) were measured 
twice weekly in the absence of fever and daily 
within 4 days of a FE. Test was considered to be 
negative if PCT was <0.5 pg/[. 
Results: 46/171 FE (27%) were classified as FUO. 
Among these, PCT remained negative in 32 (median 
0.2ng/m[) and became positive within 72h in 14 
(median 0.7) (p < 0.001) reaching LeveLs compara- 
ble to those measured in MDI (median 0.8) and 
CDI (median 0.5). Apart from PCT LeveLs at day 3, 
these two subgroups of FUO patients were cLini- 
caLLy indistinguishable: peak temperature (38.5 vs. 
38.6oc), time to defervescence (2 days, range 1-9 
vs. 2 days, range 1-6) and duration of antibiotic 
therapy (8 vs. 7 days). Thus, PCT was the only 
parameter capable of distinguishing FUO patients 
LikeLy to have fever of non-bacteria( etiology (Low 
PCT) from those LikeLy to have an occult bacteria[ 
infection (eLevated PCT). 
Conclusions: A negative PCT (<0.5 pg/[) within 72 h 
after onset of fever in neutropenic cancer patients 
